Personalized medicine: Given the individual variability in response to GLP-1 agonists, personalized treatment plans are becoming increasingly important
The primary concern relates to delayed gastric emptying , which could potentially increase the risk of pulmonary aspiration during anaesthesia
The head-to-head trial against tirzepatide (NCT06662383) is particularly interesting
some steroids are approved for hormone replacement therapy [6, 7, 8, 9, 13]
In this article, well explain what GLP-1 is, where it comes from, and what it does in simple, clear language
A 2024 scoping review by Karacabeyli and Lacaille found GLP-1 medications inhibit the NF-kB pathway one of the bodys master inflammation switches in RA and psoriasis cell models, even before weight changes